多发性硬化患者脉络丛炎症的MRI表现与5年临床残疾进展的关联
该回顾性纵向研究纳入174例多发性硬化患者(118例复发缓解型、56例进展型)和56名年龄性别匹配的健康对照,基线及平均5.5年后行3T MRI评估脉络丛体积和伪T2(pT2)以反映炎症。患者基线脉络丛体积较大(p=0.01)且pT2升高(<0.001);基线pT2与随访时临床残疾进展相关(p=0.001),控制其他因素后仍显著(p=0.030)。
要点
- 多发性硬化患者基线脉络丛体积较健康对照增大(p=0.01),脉络丛pT2升高(<0.001)。
- 基线脉络丛pT2与随访时临床残疾进展相关(p=0.001),校正混杂因素后仍显著(p=0.030)。
- 随访期间脉络丛体积和pT2的变化与复发率等临床参数变化无关。
核心结论
- MRI显示的脉络丛炎症在多发性硬化中具有临床相关性,可能参与驱动疾病进展。
研究设计与样本
- 回顾性纵向研究,纳入174例多发性硬化患者(118例复发缓解型、56例进展型)和56名年龄性别匹配的健康对照,基线及平均5.5年后行3T MRI。
主要发现
- 与健康对照相比,多发性硬化患者基线脉络丛体积较大(p=0.01)且脉络丛pT2升高(<0.001)。
- 多发性硬化样本随访期间脉络丛体积和pT2无显著增加。
- 基线脉络丛pT2与随访时临床残疾进展相关(p=0.001),控制T2病灶体积、 normalized brain volume、normalized gray matter volume和normalized thalamic volumes后仍显著(p=0.030)。
- 随访期间脉络丛体积和pT2的变化与复发率等临床参数变化无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Inflammation of the choroid plexus (CP) has been reported in multiple sclerosis (MS). The AU1 association between CP inflammation and clinical disability progression is still under debate. The objective of the current study was to assess the relationship between measures of CP inflammation and investigate their associations with clinical disability progression in MS. METHODS: In this retrospective analysis of a longitudinal study, 174 patients with MS (118 with relapsing-remitting MS and 56 with progressive MS [PMS]) and 56 healthy controls (HCs), group matched for age and sex, were imaged on a 3T MRI scanner at baseline and after an average of 5.5 years of follow-up. T2 lesion volume (T2-LV) was assessed. Regional tissue volumes were calculated. CP volume was measured, and pseudo-T2 (pT2) mapping was performed to asses CP inflammation. Group comparisons and correlations were adjusted for age and sex. RESULTS: Patients with MS presented with significantly larger CP volume (p = 0.01) and increased CP pT2 (<0.001) at baseline, when compared with HCs. CP volume and CP pT2 did not significantly increase over the follow-up in the MS sample. However, baseline CP pT2 was associated with clinical disability progression at follow-up (p = 0.001), even after controlling for all other factors significantly associated with disability progression (p = 0.030), including T2-LV, normalized brain volume, normalized gray matter volume, and normalized thalamic volumes. Changes in CP volume and CP pT2 were not related to changes in clinical parameters such as relapse rate over the course of the follow-up. DISCUSSION: CP inflammation, as evidenced by MRI, is clinically relevant in MS. CP inflammation may have a relevant role in driving disease progression.
引用
- Bergsland N, Dwyer MG, Jakimovski D, et al. Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis. Neurology. 2022. PMID: 36543575. doi:10.1212/WNL.0000000000201608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。